Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
Disease Category: Rheumatoid Arthritis
Location: United States, TX
Do You Have Moderate to Severe Rheumatoid Arthritis? Research Study RA0077
An international clinical research study is under way to evaluate and compare the safety and effectiveness of two approved drugs for people living with moderate to severe Rheumatoid Arthritis.
Qualified participants will receive study related medication and care at no cost. In order to participate in this study you must continue to take your Methotrexate as prescribed by your doctor. Other eligibility criteria will apply. You will receive compensation up to $50.00 per study visit.
To find out more about this clinical research study please contact MCRC at 214-424-0405 or on the web at www.mcrcdallas.com.
Patient Inclusion Criteria:
If you have RA, you may be eligible to participate in this important clinical research study. You may qualify to participate if you:
Patient Exclusion Criteria:
CW ID: 181924
Date Last Changed:
July 18, 2013
Metroplex Clinical Research Center8144 Walnut Hill Lane Suite 810Dallas, TX 75231Phone: 214-424-0405
Research Center Information: Metroplex Clinical Research Center
If you would like to learn more about participating in this research study, please email the trial contact using the form below.
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.
Copyright © 1995-2015 CenterWatch.